News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
157 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Business
Layoffs in California: Amgen to Slash 200 R&D Jobs, Genentech to Cut 130
It’s not uncommon for companies to announce layoffs in the final months of the year.
November 6, 2017
·
2 min read
·
Mark Terry
Two-Year Old Biotech NousCom Nabs $49M to Fund New Drug Into Clinic
The round was led by new investor Abingworth with participation from another new investor, 5AM Ventures, LSP and Versant Ventures.
November 6, 2017
·
2 min read
·
Mark Terry
Billionaire Businessman Looking to Take Stake in Debt-Ridden Teva
Shares of Teva are up more than 5 percent this morning after Israeli media reported billionaire businessman Len Blavatnik is considering taking a large stock position in the pharma giant.
November 6, 2017
·
2 min read
·
Alex Keown
Business
WuXi Biologics Partners With Pall to Reduce mAb Production Costs
The 3-year project aims to lower the cost of manufacturing mAbs significantly - to $5/g.
November 6, 2017
·
1 min read
This Drugmaker Needs to Prove It’s Not a One-Drug Wonder
‘Our track record in R&D was not great for a few years...’
November 6, 2017
·
1 min read
Business
Dentsply Sirona CFO to Step Down, Effective Nov. 10, 2017
Nicholas W. Alexos will assume position of chief financial officer effective November 10, 2017.
November 6, 2017
·
1 min read
Business
Johnson & Johnson Breaks Ground on New Facility in China
The new Ethicon factory has attracted a total investment of $180 million.
November 6, 2017
·
1 min read
Business
AI Takes Off in Biotech, Creating Demand for High Paying Jobs of $500K Plus
Salaries and total compensation can range from $300,000 to $500,000 per year for these employees – whether they have a Ph.D. or are just out of college.
November 6, 2017
·
3 min read
·
Alex Keown
BioMidwest
Gates and His Rich Buddies Back Exicure’s $11.2M Funding Round
Exicure announced it had closed on $11.2M in private financing.
November 6, 2017
·
3 min read
·
Mark Terry
Deals
Valeant Sells Sprout Pharma to a New Company ‘Associated’ With Sprout Founders
A little more than two years after acquiring Sprout, Valeant is selling off the developer of the female sex drive drug Addyi.
November 6, 2017
·
2 min read
·
Alex Keown
1 of 16
Next
